Pharma Journalist -

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced that it has signed a collaborative agreement with Plexxikon Inc., the…
Read More...

Cardurion Pharmaceuticals announced it has entered an exclusive licensing agreement with Astellas to develop and commercialize CRD-733, a PDE-9 inhibitor with the potential to improve…
Read More...

Sobi has received approval from Health Canada for a reduced dosing frequency for Orfadin (nitisinone). Orfadin is approved in combination with dietary restriction of tyrosine and…
Read More...

SMi Reports: The past attendee list has just been released in advance of the 8th annual BioBanking conference, taking place this June in London, UK SMi’s 8th annual BioBanking…
Read More...

Boehringer Ingelheim and Eli Lilly and Company announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney…
Read More...

Almac Group announced that it has expanded its US commercial packaging capabilities at its Audubon, PA facility. Addressing increased client demand of developing and bringing more…
Read More...

THE NEED FOR ADVANCED CAPABILITIES IN THE BOOMING PHARMACEUTICAL FREEZE DRYING MARKET An understanding in critical factors such as drug consistency, product quality, biological…
Read More...

The Injectable Drug Delivery conference will be hosting 2 interactive half day pre-conference workshops on the 15th May, presented by Human Factors Centre and Cambridge Consultants.…
Read More...

The Highly Potent Active Pharmaceutical Ingredients conference will be hosting 2 interactive half day post-conference workshops on the 23rd May, presented by HPAPI Project Services…
Read More...

BioAscent Discovery Limited has announced the launch of a comprehensive suite of integrated drug discovery services with immediate effect. Dr Phil Jones will be joining as Chief…
Read More...